On the contrary, studies by Zhang et al. demonstrated that blocking CDK4/6 kinases can stimulate PD-L1 expression, subsequently impairing the antitumor immune response and reducing the infiltration of lymphocytes into the tumor tissue [48]. The gene discussed is CDK4; the disease is neoplasm.